
==== Front
Sci Rep
Sci Rep
Scientific Reports
2045-2322
Nature Publishing Group UK London

39289428
72554
10.1038/s41598-024-72554-1
Article
Effects of platelet-rich plasma injection on electrical activity and biomechanics of the erector spinae muscles in lumbar myofascial pain syndrome
Li Na 123
Wang Qian 4
Ai Shaolong 4
He Hongchen 4
He Jiayuan 123
Jiang Ning jiangning21@wchscu.cn

123
1 https://ror.org/007mrxy13 grid.412901.f 0000 0004 1770 1022 The National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, Sichuan Province China
2 https://ror.org/007mrxy13 grid.412901.f 0000 0004 1770 1022 Medical Equipment Innovation Research Center, West China Hospital of Sichuan University, Chengdu, Sichuan Province China
3 https://ror.org/011ashp19 grid.13291.38 0000 0001 0807 1581 The Med-X Center for Manufacturing, Sichuan University, Chengdu, Sichuan Province China
4 https://ror.org/007mrxy13 grid.412901.f 0000 0004 1770 1022 The Department of Rehabilitation Medicine Center, West China Hospital of Sichuan University, Chengdu, Sichuan Province China
18 9 2024
18 9 2024
2024
14 2173820 5 2024
9 9 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Low back pain (LBP) is a highly prevalent disease. Among the various causes of LBP, one of the most frequent is myofascial pain syndrome (MPS) which affects the spinal stabilizer muscles. The aims of this study were to compare the differences in muscular electrical activity and biomechanical properties between the painful and non-painful sides in patients with unilateral MPS and to verify the feasibility of surface electromyography (sEMG) and MyotonPRO for assisting in MPS assessment. Forty patients with unilateral lumbar MPS were recruited via the Department of Rehabilitation Medicine Center of West China Hospital Sichuan University from October 2022 to October 2023. The electrical properties of the bilateral erector spinae muscles were characterized by sEMG signals during a trunk extension task. The following four time-domain features of sEMG were extracted: root mean square (RMS), mean absolute value (MAV), integrated EMG (iEMG), and waveform length (WL). And two frequency domain features were extracted: the median frequency (MDF) and mean power frequency (MPF). The mechanical properties of the muscles were assessed by MyotonPRO at rest. The following biomechanical parameters were acquired: oscillation frequency [Hz], dynamic stiffness [N/m], logarithmic decrement, relaxation time [ms], and Creep. The visual analog scale (VAS) was used to evaluate the pain severity, and the Oswestry Disability Index (ODI) was used to evaluate the severity of disability and disruption to lifestyle activities caused by LBP pain. The outcome measures were obtained prior to the Platelet-rich plasma (PRP) treatment and repeated two weeks after treatment. (1) Prior to the PRP treatment, all sEMG time-domain features on the painful side were significantly higher than those on the non-painful side (RMS, p < 0.001; MAV, p < 0.001; iEMG, p < 0.001; WL, p = 0.001). However, there was no significant difference in the sEMG frequency-domain features (MPF, p = 0.478; MDF, p = 0.758). On the mechanical side, there were significant differences in oscillation frequency (p = 0.041) and logarithmic decrement (p = 0.022) between the painful side and non-painful side, but no significant differences in dynamic stiffness, relaxation time, and creep (both p > 0.05). (2) Two weeks after the PRP treatment, statistically significant decreases were observed in both post-treatment VAS (p < 0.001) and ODI scales (p < 0.001), indicating the PRP treatment clinically significantly reduced the level of. MPS. This change coincided with all sEMG time-domain features, in which the values at the painful side decreased significantly (RMS, p = 0.001; MAV, p = 0.001; iEMG, p = 0.001; WL, p = 0.001). However, no significant difference in the sEMG frequency-domain features (MPF, p = 0.620; MDF, p = 0.850) was found. On the mechanical side, only logarithmic decrement on the painful side increased significantly (p < 0.001). Our combined MyotonPRO and sEMG results indicated that MPS likely leads to increased muscle tone and decreased muscle elasticity, manifested by abnormal time-domain features of sEMG and biomechanical properties. The changes in these objective measurements were agreed with the changes in subjective outcome measures of pain and function currently assessed in the patients with MPS. A single PRP treatment may alleviate muscle dysfunction caused by MPS. These preliminary results demonstrated the potential feasibility of using sEMG and MyotonPRO as tools for assessing the neuromuscular function of MPS.

Keywords

Myofascial pain syndrome
Surface electromyography
Biomechanical parameters
Platelet-rich plasma
Subject terms

Rehabilitation
Electrodiagnosis
1.3.5 project for disciplines of excellence from West China HospitalZYYC22001 Jiang Ning NSERC Discovery GrantRGPIN-04137-2016 Jiang Ning issue-copyright-statement© Springer Nature Limited 2024
==== Body
pmcIntroduction

Non-specific low back pain (LBP) is a common occurrence that affects individuals of all ages and is a major contributor to the global burden of disease1. Among the various causes of LBP, one of the most frequent is myofascial pain syndrome (MPS) which affects the spinal stabilizer muscles2. MPS has a high lifetime prevalence that affects approximately 30–85% of patients with musculoskeletal disorders3 and is usually found in the population aged from 27 to 50 years4. MPS is a chronic condition characterized by localized pain in the musculoskeletal system, often accompanied by palpable nodules and taut bands in the affected muscles, known as myofascial trigger points (MTrPs)5.

The MTrPs are hyperirritable spots, usually within a taut band of muscle fibers or in the muscle fascia which are painful on compression and can give rise to characteristic referred pain, motor dysfunction, and autonomic phenomena6. The development of MTrPs is primarily attributed to muscle tissue injury caused by factors such as trauma, abnormal posture, sports injuries, and dysfunction of the motor endplate7. Travell and Simons proposed the “energy crisis theory” to explain the formation of MTrPs8. Specifically, dysfunction of the motor endplate leads to an excessive release of acetylcholine9, which in turn causes sustained contraction of skeletal muscle fibers, the formation of contraction nodules, and tissue tension. Further, persistent muscle contraction results in local ischemia, hypoxia, and increased metabolic activity, triggering the release of a multitude of pain-inducing substances within the affected tissues and forming a vicious cycle10. MTrPs can be further categorized as active or latent. Active MTrPs are responsible for clinical symptoms, and their referred pain reproduces the patients’ reported symptoms. On the other hand, latent MTrPs may cause motor dysfunction such as stiffness, limited range of motion, and fatigability, but do not typically produce spontaneous sensory symptoms unless they are stimulated11. However, Quintner et al.12 claimed that the explanation for MPS caused by MTrPs lacks external validity.

Clinically, the identification of MTrPs and the assessment of muscle tone and tissue stiffness during a physical exam are commonly done by manual palpation, but this approach is subjective, requires experienced operators and different inter-rater reliabilities have been reported13. Recently, several objective techniques have been developed to quantitatively identify muscle stiffness by distinguishing the harder MTrPs from the surrounding normal muscle, including shear wave elastography14 and magnetic resonance elastography15. However, as these techniques are expensive and require technical expertise and complicated procedures, they are still not widely used in clinical practice and research. Despite the limited external validations, the diagnosis of MPS and its treatment protocols have been widely accepted by many practitioners. Therefore, it is necessary to have more convenient methods to objectively diagnose and quantify the physical and physiological characteristics of MTrPs based on two common manifestations of MPS (i.e., motor endplate dysfunction and tissue tension)8, to clarify the pathophysiology of MTrPs and improve treatment.

The electrophysiology of MTrPs typically generates sustained, rapid, and low-amplitude abnormal electrical signals, such as spontaneous electrical activity or endplate noise, which can be detected using needle electromyography (EMG)16. The presence of MTrPs can be demonstrated by an increase in resting muscle activity17. Surface EMG (sEMG) is a non-invasive tool commonly used to evaluate neuromuscular function. Wytrążek et al.13 observed that MTrPs evoked an increase in sEMG amplitude at rest, but did not affect sEMG amplitude during maximal voluntary contraction (MVC). In contrast, according to Ge et al.11, during shoulder abduction at 25% MVC, the EMG activity in the upper trapezius muscle significantly increased when latent MTrPs were present compared to non-MTrPs. Currently, there is no consensus about the changes in sEMG activity in MTrPs. More recently, a new handheld, portable, non-invasive MyotonPRO device (Myoton AS, Tallinn, Estonia) has already proven to be objective and reliable in measuring biomechanical parameters of muscle properties18,19, and its validity has been widely confirmed20,21. The MyotonPRO employs a measurement method defined as the mechanical dynamic response method19. Studies have demonstrated that parameters of MyotonPRO, such as frequency, stiffness, and decrement, can be used to distinguish the MTrPs and non-MTrPs region of the infraspinatus in subjects with chronic shoulder pain22,23.

There is currently no standard treatment for patients with MPS. Clinically available treatments are trigger point injections, dry needling, manual therapy, physical exercise, and self-myofascial release10,24,25. Ultrasound-guided interventional procedures have recently been receiving increased attention as a therapy for treating MPS26. Platelet-rich plasma (PRP) is a concentrated platelet derived from whole blood after centrifugation, which can promote tissue repair and regeneration by utilizing the growth factors in autologous platelets and can regulate inflammation and immunity27,28. Studies have confirmed that PRP injection has a significant therapeutic effect on chronic tendon injury29 and chronic muscle injury30, but not on acute muscle injury31. Recently, Agarwal et al. demonstrated that PRP appears to be a more effective treatment approach compared to dry needling in the management of MTrPs in MPS patients32. Sakalys et al. also proved that PRP injections more effectively relieve pain in MPS of masseter muscle than lidocaine injections33. The application of PRP in the treatment of MPS presents evident feasibility and potential mechanisms, yet further research is required to determine its long-term effects and optimal application strategies.

Given the clinical significance of assessing neuromuscular function in MPS, the primary purpose of this study was to compare the differences in biomechanical parameters and muscle electrical activity between the painful and non-painful sides in patients with unilateral MPS. Additionally, this study aimed to evaluate the effects of PRP on muscle electrical activity and biomechanical parameters in patients with MPS, determine the feasibility of sEMG and MyotonPRO to assess the neuromuscular function of MPS and to evaluate the therapeutic effects of PRP.

Materials and methods

Study design

A non-randomized single-group design trial was implemented in the Department of Rehabilitation Medicine Center of West China Hospital Sichuan University from October 2022 to October 2023. The Institutional Review Board of the West China Hospital of Sichuan University authorized this work from the ethical point of view (WCHSCU_2023_99). The protocol was registered at the Chinese Clinical Trial Register (ChiCTR2300074199) as a clinical trial.

Participants

Forty participants with unilateral lumbar MPS were recruited randomly. The following inclusion criteria were applied: (1) aged 18–70 years, (2) males or females, (3) meet the diagnostics of MPS: (1) a tender spot located with palpation, with or without referral of pain; (2) recognition of symptoms by the patient during palpation of the tender spot; and (3) at least three of the following: (a) muscle stiffness or spasm, (b) limited range of motion of an associated joint, (c) pain worsening with stress, and (d) palpation of a taut band and/or nodule associated with the tender spot. 4) Symptoms persist for more than six months. The exclusion criteria were: (1) any neurological signs consistent with nerve root compression; (2) a history of lumbar surgery or traumatic event; (3) pregnancy; or (4) known malignancy. After being advised of the purpose and potential risks of the study, all participants provided written informed consent and conducted in accordance with the Declaration of Helsinki.

PRP preparation and injection

Approximately 40 mL of whole blood was drawn from the elbow vein using a specialized 20G needle. The blood was then mixed with an anticoagulant (4 mL, 0.04 g/mL) at a ratio of 9:1 to prevent the formation of microbubbles and was distributed into an anticoagulant vacuum tube. PRP was prepared using commercially available kits (WEGO Platelet-Rich Plasma Preparation Kits, WEGO Ltd. Shandong, China). The centrifugation took place at room temperature. The sample was centrifuged at 1400 rpm for 10 min to obtain the buffy coat, followed by a second centrifugation at 2350 rpm for 5 min. After removing the supernatant, approximately 6 mL PRP would be obtained. Calcium chloride and thrombin were added to keep the bio-activity of PRP. The prepared PRP was not cooled before centrifugation and was immediately injected after preparation. Ultrasound-guided injection of PRP in lumbar erector spinae muscle (ES) targeted both MTrPs and their surrounding myofascial with meticulous layer-by-layer release (Fig. 1). The injection was performed by an experienced rehabilitation physician with more than 10 years of experience.Fig. 1 The schematic of the ultrasound-guided injection of platelet-rich plasma (PRP). PM: Proas major muscle; QL = Quardratus lumborum muscle; ES = Erector spinae muscle; TP = Transverse process.

Outcome measures

All outcome measures were assessed at baseline (before the treatment) and two weeks after the treatment.

Clinical assessment

The pain severity of the participants was evaluated using the visual analog scale (VAS), and the Oswestry Disability Index (ODI) was used to evaluate the severity of disability and disruption to lifestyle activities caused by LBP pain.

Biomechanical assessment

Participants lay prone on the bed and were instructed to completely relax. The operator first marked the body surface by palpating the second lumbar vertebra (L2) muscle, the third lumbar vertebra (L3) muscle, and the fourth lumbar vertebra (L4) muscle, then the ES was marked with an oil pencil at 2.5 cm on both sides of the spinous process of L3 (see the points marked with a red cross in Fig. 2). Biomechanical parameters of the bilateral ES were recorded using a handheld, non-invasive MyotonPRO device (Myoton AS, Tallinn, Estonia). The following mechanical properties were measured: (1) Oscillation frequency [Hz], which characterizes the tone or tension of superficial skeletal muscles in their passive or resting state without voluntary contraction; The higher the value, the higher the muscle tone. (2) Dynamic stiffness [N/m] indicates the resistance of biological soft tissues to a force of deformation; The higher the value, the muscle becomes stiffer. (3) Logarithmic decrement is related to muscle elasticity; The lower the value, the muscle becomes more elastic. (4) Relaxation time [ms] characterizes tissue’s recovery time from displacement; The higher a tissue’s tension or stiffness, the faster a tissue recovers its shape, meaning the lower the value. (5) Creep is the ratio of relaxation and deformation time, which characterizes the gradual elongation of tissue over time when placed under constant tensile stress; The higher a tissue’s tension, structural integrity, or stiffness, the higher its resistance to creep, meaning the lower the value. To ensure accuracy, the MyotonPRO measurements were conducted by two experienced physiotherapists (N.L. and Q.W.). Five values measured by the same therapist at the same position were averaged as the final value.Fig. 2 Biomechanical assessment. a Measurement position of MyotonPRO. b Measurement process of MyotonPRO.

Electromyography

A wireless sEMG system (FREEEMG BTS, Milano, Italy) was used to record the sEMG signals at a sampling rate of 1000 Hz. Before the experiment, the skin of the lumbar area was shaved lightly and wiped with alcohol pads to provide a low skin impedance condition for sEMG signal acquisition. Two Ag/AgCl electrode pairs (Kendall™ 930, Cardinal Health Inc., Dublin, Ohio, USA) were attached to the muscle abdomen of both ES (see Fig. 3a). The participants were asked to perform an isometric trunk extension exercise (see Fig. 3b). The participants were prone in their relaxed position before each trial started. Then, the participants conducted six trials. Each trial consisted of a 5-s MVC and a 5-s rest period between contractions under verbal motivation from the experimenter. Subsequent data analysis used only the stable 3-s EMG data from each 5-s contraction.Fig. 3 Experimental protocol. a The position of the electrodes. b Test task demonstrated by researcher.

The raw sEMG signals were digitally filtered by a 50-Hz notch filter and bandpass 3rd order Butterworth filter between 20 and 450 Hz. Then, the sEMG signals were segmented into a series of 200 ms sliding windows with an increment of 50 ms. Four time-domain features of sEMG were extracted in each sliding window, namely, root mean square (RMS), mean absolute value (MAV), integrated EMG (iEMG), and waveform length (WL). Additionally, the frequency domain features used are the median frequency (MDF) and mean power frequency (MPF). The average of each feature was computed across all six trials.

Statistical analysis

The descriptive statistics are reported in the mean and standard deviation (± SD) format. The Shapiro–Wilk test was used to assess the normality of the data distribution. Additionally, the assumption of homogeneity of variances was investigated using Levene’s test. To compare the differences in clinical assessment, sEMG features, and biomechanical parameters between the painful side and the non-painful sides, as well as pre- and post-PRP treatment, statistical analyses were performed using a paired t-test, with a significance level of 0.05. All statistical analyses were performed using SPSS version 25.0 (SPSS, Inc., IBM, Chicago, IL, United States).

Results

Participants characteristics

During the baseline data collection, a total of 40 participants with unilateral lumbar MPS were recruited and participated in the pre-treatment measurement, but only 33 participants with MPS on pailful side received PRP intervention and completed full procedures due to conflicting schedules. Thus, comparisons between the painful and non-painful sides were conducted with data from 40 participants (40/40), whereas pre- and post-PRP treatment comparisons were based on the 33 participants who completed full procedures (33/33). The characteristics of the participants are described in Table 1.Table 1 Descriptive statistics of all participants represented as mean (± SD).

	Pre-treatment	Post-treatment	
T (n = 40)	F (n = 23)	M (n = 17)	T (n = 33)	F (n = 20)	Male (n = 13)	
Age (years)	42.2 ± 4.7	40.2 ± 4.7	43.6 ± 5.2	41.8 ± 4.5	42.2 ± 4.4	40.6 ± 4.8	
Height (cm)	161.7 ± 4.5	154.7 ± 4.5	166.5 ± 6.3	162.1 ± 4.2	155.6 ± 4.3	166.1 ± 6.1	
Weight (kg)	60.5 ± 6.5	59.5 ± 6.4	61.6 ± 11.9	61.1 ± 6.2	60.5 ± 6.6	61.9 ± 11.1	
BMI (kg/m2)	23.4 ± 4.8	24.6 ± 5.5	22.5 ± 3.7	23.4 ± 4.8	25.1 ± 4.5	22.4 ± 4.6	
T: total; F: female; M: male; BMI: body mass index; SD, standard deviation.

Clinical assessment

Statistically significant decreases were observed in both post-treatment VAS levels (pre: 4.3 ± 1.0; post: 2.2 ± 0.8; p < 0.001) and ODI levels (pre: 20.8 ± 6.5; post: 13.8 ± 5.4; p < 0.001) compared to pre-treatment (Fig. 4). Evidently, the clinical assessments indicated a significant reduction in MPS pain level following the PRP treatment.Fig. 4 Clinical measurements pre- and post-intervention. Lower values of both VAS and ODI indicate lower severity of perceived pain. * indicates statistical significance at p < 0.05.

Biomechanical analysis

Baseline data

The paired t-test analysis showed that before PRP treatment, oscillation frequency reflecting muscle tension at rest (p = 0.041, see Fig. 5a) and logarithmic decrement (p = 0.022, see Fig. 5c) reflecting muscle elasticity were significantly higher than those on the non-painful side. This indicates that the painful side generally has higher muscle tension and lower muscle elasticity. However, there were no significant differences in relaxation time (p = 0.398, see Fig. 5d) and creep (p = 0.510, see Fig. 5e) which reflect the viscoelastic properties of muscles, and in dynamic stiffness (p = 0.059, see Fig. 5b) reflecting muscle stiffness.Fig. 5 Biomechanical parameters of the painful side and non-painful side, before the intervention. * indicates statistical significance at p < 0.05. P: painful side; NP: non-painful side.

Post-treatment

The logarithmic decrement on the painful side was significantly higher after treatment than before treatment (pre: 1.48 ± 0.43; post: 1.59 ± 0.36; p < 0.001), but there was no statistical difference in logarithmic decrement between the painful side and the non-painful side after treatment (painful side: 1.59 ± 0.36; non-painful side: 1.63 ± 0.37; p = 0.076), see Fig. 6c. Furthermore, the logarithmic decrement (pre: 1.40 ± 0.35; post: 1.63 ± 0.36; p < 0.001) and the creep (pre: 1.36 ± 0.35; post: 1.39 ± 0.32; p = 0.035) on the non-painful side was significantly higher after treatment than before treatment, see Fig. 6c,e. However, the remaining parameters were not statistically different between before and after treatment, or between the painful side and the non-painful side (p > 0.05), see Fig. 6a–e.Fig. 6 Biomechanical parameters of the painful side and non-painful side, before and after the intervention. * indicates statistical significance at p < 0.05. P: painful side; NP: non-painful side; Pre: pre-treatment; Post: post-treatment.

Electrophysiological analysis

Baseline data

The time-domain features of the painful side were significantly higher than those in the non-painful side (RMS, p < 0.001; MAV, p < 0.001; iEMG, p < 0.001; WL, p = 0.001; see Fig. 7a–d). Additionally, there was no difference in frequency-domain features between the painful side and the non-painful side (MPF, p = 0.478; MDF, p = 0.758; see Fig. 7e,f).Fig. 7 sEMG features of the painful side and non-painful side, before the intervention. * indicates statistical significance at p < 0.05. P: painful side; NP: non-painful side.

Post-treatment

After PRP treatment, the features of the painful side reflecting sEMG energy, i.e., RMS (pre: 77.1 ± 35.9; post: 67.3 ± 33.9; p = 0.001), MAV (pre: 60.7 ± 28.2; post: 53.1 ± 26.6; p = 0.001), iEMG (pre: 112131.2 ± 5642.8; post:10666.9 ± 5315.5; p = 0.001) and WL (pre: 9125.4 ± 4336.7; post: 8127.4 ± 4298.7; p = 0.008), decreased significantly, see Fig. 8a–d. In addition, the RMS (pre: 62.1 ± 25.1; post: 68.5 ± 26.5; p = 0.006) and iEMG (pre: 9769.5 ± 3955.7; post: 11049.7 ± 4006.6; p < 0.001) on non-painful side were significantly higher after treatment than before treatment, see Fig. 8a, c. However, there is no significant difference in the frequency-domain features of painful side before and after PRP treatment, see Fig. 8e, f. Obviously, there were no significant differences in all sEMG features between the painful side and non-painful sides after PRP treatment (p > 0.05), see Fig. 8.Fig. 8 sEMG features of the painful side and non-painful side, before and after the intervention. * indicates statistical significance at p < 0.05. P: painful side; NP: non-painful side; Pre: pre-treatment; Post: post-treatment.

Discussion

Pain is a global public health problem that directly results in a decrease in functional activity34. The low back area is one of the most common sites for chronic pain2. Lumbar MPS is the most recurring type of LBP and a frequent cause for visiting a pain clinic35. MPS is seen most commonly between 27 and 50 years of age4. In our study, the mean age of the patients was 42 years old, which was consistent with other studies in the literature.

MTrPs can cause local motor dysfunctions such as muscle cramps and weakness, restricted joint range of motion, and altered motor control strategy36, and may lead to additional recruitment of motor units to compensate for a decreased discharge rate of low-threshold motor units, associated with muscle pain and muscle fatigue37. Manfredini et al. found that there was no significant difference in sEMG values of muscles on the painful and non-painful sides in patients with unilateral MPS of jaw muscles either at rest or during clenching tasks38. Ciubotariu et al.39 confirmed that during isometric contraction, muscle pain causes decreased force production, endurance time, and decreased activation of the painful muscle. Jiang et al.40 found that the RMS from the MPS group was slightly higher than that of the healthy group, but the MDF from the MPS group was lower than that of the healthy group. Our study, however, found that during MVC contraction, the muscle activity of the painful side was significantly higher than that of the non-painful side, while no difference in frequency-domain features between the two sides was found. There is no consensus on the effect of pain on the electrical activity of muscles. This may be due to differences in motor control strategy caused by pain, namely “tight control” and “loose control”41. Loose control protects against high muscle forces but eventually causes excessive tensile strains of tissues. On the contrary, tight control protects against large tissue strains from uncontrolled movement, but its long-term negative consequences can lead to sustained muscle activity. Based on the “motor control strategy” and “energy crisis theory”, the explanation for our findings may be that the changes in motor control induced by MPS may be more consistent with tight control, leading to sustained muscle activity resulting in abnormal increases in muscle electrical activity. However, this sustained muscle activity does not seem to lead to muscle fatigue.

Pain may cause the muscles on the painful side to remain in a contracted state for an extended period of time. This could be one of the reasons for increased muscle tone and stiffness42. Masaki et al. demonstrated that LBP-induced muscle spasms could cause an increase in multifidus muscle stiffness43. However, Kong et al. found that there were no significant differences in the stiffness of the back muscles between firefighters with and without LBP history44. Similarly, according to the “energy crisis theory”, the dysfunction of the motor endplates in MTrPs may contribute to the sustained contraction of skeletal muscle fibers and subsequent muscle cramping and tissue tension8. The results of this study found that the oscillation frequency and logarithmic decrement between the painful side and the non-painful side are different, which indicated that MPS may lead to higher muscle tone and lower muscle elasticity. This is consistent with previous research45–47.

Intramuscular injections are considered the recommended treatment for MTrPs48. Dry needling and local anesthesia are the most used modalities49. PRP is a novel treatment of MTrPs. As a method of delivering a high concentration of autologous growth factors and bioactive compounds at a low cost and with minimal invasiveness, it has become more popular28. In a study comparing the effectiveness of PRP injection versus dry needling for the management of MTrPs in the masseter muscle, the results indicated that PRP appears to be a superior treatment modality in managing MTrPs compared to dry needling 32. Another study compared the effectiveness of local anesthesia, botulinum toxin, and PRP injections for treating MTrPs in the masseter muscle, the results demonstrated that botulinum toxin injection seemed superior at the 3-month follow-up and remained effective up to 6 months49. The findings in the present study suggest that a single injection of PRP was enough to alleviate pain and improve the level of function in activities of daily living in patients with MPS. This is consistent with previous research32,49. It is noteworthy that our study revealed a notable reduction in muscle electrical activity on the painful side after PRP treatment. This could potentially be attributed to the disruption of existing contracture nodules and accelerated tissue repair caused by PRP injection targeting MTrPs. Additionally, the treatment may contribute to reduced inflammation, improved blood circulation, and inhibition of sustained muscle fiber contraction and continuous discharge8. There also has been some evidence that force can be transmitted through the muscular connective tissue and could lead to blockage of the spindle and/or its overexcitation50. This could also explain our findings of decreased sEMG activity after treatment. It is also noteworthy that our study found certain biomechanical parameters and sEMG features of the non-painful side changed, despite only the painful side receiving PRP treatment. This may be due to improved function on the painful side, resulting in reduced compensation on the non-painful side.

The present study has some limitations. Firstly, it did not include a control group, such as one that received no treatment or one that received only other treatment without PRP injection. Secondly, this study relied only on physicians’ experience in diagnosing MTrPs, lacking objective assessment methods, which likely resulted in heterogeneity due to the absence of MTrPs among the study population, and future studies should attempt to use ultrasound localization to reduce heterogeneity. Furthermore, relying only on verbal encouragement from the experimenter for participants to perform MVC contractions during trunk extension tasks may affect the consistency of sEMG results due to inconsistent muscle contraction states (dynamic or static). In the future, incorporating tasks such as resisted extension to control for the contraction condition could enhance the reliability of sEMG outcomes in both time domain and frequency domain. It is important to note that most of the current validity studies are related to the ‘dynamic stiffness’ parameter of the MyotonPRO devices. Therefore, conclusions based on the other parameters should be drawn with caution. Lastly, the present study only focused on the immediate effects of PRP, with no follow-up outcomes regarding PRP provided.

Conclusion

This study made a preliminary investigation of the differences in muscle electrical activity and biomechanical properties between the painful and non-painful sides in patients with unilateral lumbar MPS and verified the feasibility of sEMG and MyotonPRO for assisting in MPS assessment. Our results indicated that MPS likely leads to abnormal time-domain features of sEMG rather than the frequency-domain features, and leads to increased muscle tone and decreased muscle elasticity. A single PRP treatment may alleviate muscle dysfunction caused by MPS. These preliminary results demonstrated the potential feasibility of using sEMG and MyotonPRO as tools for assessing the neuromuscular function of MPS.

Abbreviations

LBP Low back pain

MPS Myofascial pain syndrome

MTrPs Myofascial trigger points

sEMG Surface electromyography

PRP Platelet-rich plasma

VAS Visual analog scale

ODI Oswestry disability index

ES Erector spinae muscle

RMS Root mean square

MAV Mean absolute value

iEMG Integrated electromyography

WL Waveform length

MDF Median frequency

MPF Mean power frequency

Acknowledgements

Not applicable.

Author contributions

Conceptualization, N.L., N.J., H.C.H., and J.Y.H.; methodology, N.L., Q.W., H.C.H., N.J., and J.Y.H.; data analysis, N.L. and Q.W.; investigation, N.L., Q.W., H.C.H., J.Y.H., and N.J.; resources, J.Y.H., H.C.H., and N.J.; data curation, N.L., S.L.A., and Q.W.; original draft preparation, N.L. and N.J.; review and editing, N.L., Q.W., S.L.A., H.C.H., and N.J.; supervision, J.Y.H., H.C.H. and N.J.; project administration, J.Y.H., H.C.H., and N.J.; funding acquisition, J.Y.H., H.C.H., and N.J. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by a 1.3.5 project for disciplines of excellence from West China Hospital (#ZYYC22001), an NSERC Discovery Grant (#RGPIN-04137-2016), and the Key Research Project Grant form the National Clinical Research Center for Geriatrics (#Z2023YY001).

Data availability

To request a copy of the data from this study, please contact the corresponding author.

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

The study was conducted by the declaration of Helsinki and approved by the ethics subcommittee of West China Hospital of Sichuan University (WCHSCU_2023_99).

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Maher C Underwood M Buchbinder R Non-specific low back pain Lancet 2017 389 10070 736 747 10.1016/S0140-6736(16)30970-9 27745712
Maher, C., Underwood, M. & Buchbinder, R. Non-specific low back pain. Lancet 389(10070), 736–747 (2017).27745712
2. De Andrés J Adsuara VM Palmisani S A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans Reg. Anesth. Pain Med. 2010 35 3 255 260 10.1097/AAP.0b013e3181d23241 20921836
De Andrés, J. et al. A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans. Reg. Anesth. Pain Med. 35(3), 255–260 (2010).20921836
3. Skootsky SA Jaeger B Oye RK Prevalence of myofascial pain in general internal medicine practice West. J. Med. 1989 151 2 157 160 2788962
Skootsky, S. A., Jaeger, B. & Oye, R. K. Prevalence of myofascial pain in general internal medicine practice. West. J. Med. 151(2), 157–160 (1989).2788962
4. Vázquez-Delgado E Cascos-Romero J Gay-Escoda C Myofascial pain syndrome associated with trigger points: A literature review. (I): Epidemiology, clinical treatment and etiopathogeny Med. Oral Patol. Oral Cir. Bucal. 2009 14 10 e494 8 10.4317/medoral.14.e494 19680218
Vázquez-Delgado, E., Cascos-Romero, J. & Gay-Escoda, C. Myofascial pain syndrome associated with trigger points: A literature review. (I): Epidemiology, clinical treatment and etiopathogeny. Med. Oral Patol. Oral Cir. Bucal. 14(10), e494-8 (2009).19680218
5. Yap EC Myofascial pain–an overview Ann. Acad. Med. Singap. 2007 36 1 43 48 10.47102/annals-acadmedsg.V36N1p43 17285185
Yap, E. C. Myofascial pain–an overview. Ann. Acad. Med. Singap. 36(1), 43–48 (2007).17285185
6. Lavelle ED Lavelle W Smith HS Myofascial trigger points Med. Clin. N. Am. 2007 91 2 229 239 10.1016/j.mcna.2006.12.004 17321283
Lavelle, E. D., Lavelle, W. & Smith, H. S. Myofascial trigger points. Med. Clin. N. Am. 91(2), 229–239 (2007).17321283
7. Shah JP Thaker N Heimur J Myofascial trigger points then and now: A historical and scientific perspective PMR 2015 7 7 746 761 10.1016/j.pmrj.2015.01.024
Shah, J. P. et al. Myofascial trigger points then and now: A historical and scientific perspective. PMR 7(7), 746–761 (2015).
8. Simons DG Review of enigmatic MTrPs as a common cause of enigmatic musculoskeletal pain and dysfunction J. Electromyogr. Kinesiol. 2004 14 1 95 107 10.1016/j.jelekin.2003.09.018 14759755
Simons, D. G. Review of enigmatic MTrPs as a common cause of enigmatic musculoskeletal pain and dysfunction. J. Electromyogr. Kinesiol. 14(1), 95–107 (2004).14759755
9. Gerwin RD A new unified theory of trigger point formation: Failure of pre- and post-synaptic feedback control mechanisms Int. J. Mol. Sci. 2023 24 9 8142 10.3390/ijms24098142 37175845
Gerwin, R. D. A new unified theory of trigger point formation: Failure of pre- and post-synaptic feedback control mechanisms. Int. J. Mol. Sci. 24(9), 8142 (2023).37175845
10. Urits I Charipova K Gress K Treatment and management of myofascial pain syndrome Best Pract. Res. Clin. Anaesthesiol. 2020 34 3 427 448 10.1016/j.bpa.2020.08.003 33004157
Urits, I. et al. Treatment and management of myofascial pain syndrome. Best Pract. Res. Clin. Anaesthesiol. 34(3), 427–448 (2020).33004157
11. Ge HY Monterde S Graven-Nielsen T Latent myofascial trigger points are associated with an increased intramuscular electromyographic activity during synergistic muscle activation J. Pain. 2014 15 2 181 187 10.1016/j.jpain.2013.10.009 24189107
Ge, H. Y. et al. Latent myofascial trigger points are associated with an increased intramuscular electromyographic activity during synergistic muscle activation. J. Pain. 15(2), 181–187 (2014).24189107
12. Quintner JL Bove GM Cohen ML A critical evaluation of the trigger point phenomenon Rheumatology (Oxford) 2015 54 3 392 399 10.1093/rheumatology/keu471 25477053
Quintner, J. L., Bove, G. M. & Cohen, M. L. A critical evaluation of the trigger point phenomenon. Rheumatology (Oxford) 54(3), 392–399 (2015).25477053
13. Wytrążek M Huber J Lipiec J Evaluation of palpation, pressure algometry, and electromyography for monitoring trigger points in young participants J. Manip. Physiol. Ther. 2015 38 3 232 243 10.1016/j.jmpt.2014.12.005
Wytrążek, M. et al. Evaluation of palpation, pressure algometry, and electromyography for monitoring trigger points in young participants. J. Manip. Physiol. Ther. 38(3), 232–243 (2015).
14. Sikdar, S., Shah, J. P., Gilliams, E., et al. Assessment of myofascial trigger points (MTrPs): A new application of ultrasound imaging and vibration sonoelastography. In: Proceedings of the Annu Int Conf IEEE Eng Med Biol Soc, Vancouver (2008)
15. Chen Q Bensamoun S Basford JR Identification and quantification of myofascial taut bands with magnetic resonance elastography Arch. Phys. Med. Rehabil. 2007 88 12 1658 1661 10.1016/j.apmr.2007.07.020 18047882
Chen, Q. et al. Identification and quantification of myofascial taut bands with magnetic resonance elastography. Arch. Phys. Med. Rehabil. 88(12), 1658–1661 (2007).18047882
16. Hubbard DR Berkoff GM Myofascial trigger points show spontaneous needle EMG activity Spine (Phila Pa 1976) 1993 18 13 1803 7 10.1097/00007632-199310000-00015 8235865
Hubbard, D. R. & Berkoff, G. M. Myofascial trigger points show spontaneous needle EMG activity. Spine (Phila Pa 1976) 18(13), 1803–7 (1993).8235865
17. Chou LW Hsieh YL Kao MJ Remote influences of acupuncture on the pain intensity and the amplitude changes of endplate noise in the myofascial trigger point of the upper trapezius muscle Arch. Phys. Med. Rehabil. 2009 90 6 905 912 10.1016/j.apmr.2008.12.020 19480864
Chou, L. W. et al. Remote influences of acupuncture on the pain intensity and the amplitude changes of endplate noise in the myofascial trigger point of the upper trapezius muscle. Arch. Phys. Med. Rehabil. 90(6), 905–912 (2009).19480864
18. Jiménez-Sánchez C Ortiz-Lucas M Bravo-Esteban E Myotonometry as a measure to detect myofascial trigger points: An inter-rater reliability study Physiol. Meas. 2018 39 11 115004 10.1088/1361-6579/aae9aa 30475742
Jiménez-Sánchez, C. et al. Myotonometry as a measure to detect myofascial trigger points: An inter-rater reliability study. Physiol. Meas. 39(11), 115004 (2018).30475742
19. Muckelt PE Warner MB Cheliotis-James T Protocol and reference values for minimal detectable change of MyotonPRO and ultrasound imaging measurements of muscle and subcutaneous tissue Sci. Rep. 2022 12 1 13654 10.1038/s41598-022-17507-2 35953503
Muckelt, P. E. et al. Protocol and reference values for minimal detectable change of MyotonPRO and ultrasound imaging measurements of muscle and subcutaneous tissue. Sci. Rep. 12(1), 13654 (2022).35953503
20. Bartsch K Brandl A Weber P Assessing reliability and validity of different stiffness measurement tools on a multi-layered phantom tissue model Sci. Rep. 2023 13 1 815 10.1038/s41598-023-27742-w 36646734
Bartsch, K. et al. Assessing reliability and validity of different stiffness measurement tools on a multi-layered phantom tissue model. Sci. Rep. 13(1), 815 (2023).36646734
21. Brandl A Acikalin E Bartsch K Reliability and validity of an app-assisted tissue compliance meter in measuring tissue stiffness on a phantom model PeerJ 2024 12 e17122 10.7717/peerj.17122 38464760
Brandl, A. et al. Reliability and validity of an app-assisted tissue compliance meter in measuring tissue stiffness on a phantom model. PeerJ 12, e17122 (2024).38464760
22. Roch M Morin M Gaudreault N The MyotonPRO: A reliable tool for quantifying the viscoelastic properties of a trigger point on the infraspinatus in non-traumatic chronic shoulder pain J. Bodyw. Mov. Ther. 2020 24 4 379 385 10.1016/j.jbmt.2020.05.002 33218538
Roch, M., Morin, M. & Gaudreault, N. The MyotonPRO: A reliable tool for quantifying the viscoelastic properties of a trigger point on the infraspinatus in non-traumatic chronic shoulder pain. J. Bodyw. Mov. Ther. 24(4), 379–385 (2020).33218538
23. Gordon CM Andrasik F Schleip R Myofascial triggerpoint release (MTR) for treating chronic shoulder pain: A novel approach J. Bodyw. Mov. Ther. 2016 20 3 614 622 10.1016/j.jbmt.2016.01.009 27634087
Gordon, C. M. et al. Myofascial triggerpoint release (MTR) for treating chronic shoulder pain: A novel approach. J. Bodyw. Mov. Ther. 20(3), 614–622 (2016).27634087
24. Barbero M Schneebeli A Koetsier E Myofascial pain syndrome and trigger points: Evaluation and treatment in patients with musculoskeletal pain Curr. Opin. Support Palliat. Care 2019 13 3 270 276 10.1097/SPC.0000000000000445 31313700
Barbero, M. et al. Myofascial pain syndrome and trigger points: Evaluation and treatment in patients with musculoskeletal pain. Curr. Opin. Support Palliat. Care 13(3), 270–276 (2019).31313700
25. Chou Y Chiou HJ Wang HK Ultrasound-guided dextrose injection treatment for chronic myofascial pain syndrome: A retrospective case series J. Chin. Med. Assoc. 2020 83 9 876 879 10.1097/JCMA.0000000000000339 32349034
Chou, Y. et al. Ultrasound-guided dextrose injection treatment for chronic myofascial pain syndrome: A retrospective case series. J. Chin. Med. Assoc. 83(9), 876–879 (2020).32349034
26. Diep D Chen KJQ Kumbhare D Ultrasound-guided interventional procedures for myofascial trigger points: A systematic review Reg. Anesth. Pain Med. 2021 46 1 73 80 10.1136/rapm-2020-101898 33159004
Diep, D., Chen, K. J. Q. & Kumbhare, D. Ultrasound-guided interventional procedures for myofascial trigger points: A systematic review. Reg. Anesth. Pain Med. 46(1), 73–80 (2021).33159004
27. Cecerska-Heryć E Goszka M Serwin N Applications of the regenerative capacity of platelets in modern medicine Cytokine Growth Factor Rev. 2022 64 84 94 10.1016/j.cytogfr.2021.11.003 34924312
Cecerska-Heryć, E. et al. Applications of the regenerative capacity of platelets in modern medicine. Cytokine Growth Factor Rev. 64, 84–94 (2022).34924312
28. Gao H Zhao Z Li J Platelet-rich plasma promotes skeletal muscle regeneration and neuromuscular functional reconstitution in a concentration-dependent manner in a rat laceration model Biochem. Biophys. Res. Commun. 2023 672 185 192 10.1016/j.bbrc.2023.05.123 37354612
Gao, H. et al. Platelet-rich plasma promotes skeletal muscle regeneration and neuromuscular functional reconstitution in a concentration-dependent manner in a rat laceration model. Biochem. Biophys. Res. Commun. 672, 185–192 (2023).37354612
29. Filardo G Di Matteo B Kon E Platelet-rich plasma in tendon-related disorders: Results and indications Knee Surg. Sports Traumatol. Arthrosc. 2018 26 7 1984 1999 10.1007/s00167-016-4261-4 27665095
Filardo, G. et al. Platelet-rich plasma in tendon-related disorders: Results and indications. Knee Surg. Sports Traumatol. Arthrosc. 26(7), 1984–1999 (2018).27665095
30. Dadgostar H Fahimipour F Pahlevan Sabagh A Corticosteroids or platelet-rich plasma injections for rotator cuff tendinopathy: A randomized clinical trial study J. Orthop. Surg. Res. 2021 16 1 333 10.1186/s13018-021-02470-x 34020672
Dadgostar, H. et al. Corticosteroids or platelet-rich plasma injections for rotator cuff tendinopathy: A randomized clinical trial study. J. Orthop. Surg. Res. 16(1), 333 (2021).34020672
31. Grassi A Napoli F Romandini I Is Platelet-rich plasma (PRP) effective in the treatment of acute muscle injuries? A systematic review and meta-analysis Sports Med. 2018 48 4 971 989 10.1007/s40279-018-0860-1 29363053
Grassi, A. et al. Is Platelet-rich plasma (PRP) effective in the treatment of acute muscle injuries? A systematic review and meta-analysis. Sports Med. 48(4), 971–989 (2018).29363053
32. Agarwal V Gupta A Singh H Comparative efficacy of platelet-rich plasma and dry needling for management of trigger points in masseter muscle in myofascial pain syndrome patients: A randomized controlled trial J. Oral Fac. Pain Headache. 2022 36 3–4 253 262 10.11607/ofph.3188
Agarwal, V. et al. Comparative efficacy of platelet-rich plasma and dry needling for management of trigger points in masseter muscle in myofascial pain syndrome patients: A randomized controlled trial. J. Oral Fac. Pain Headache. 36(3–4), 253–262 (2022).
33. Sakalys D Rokicki JP Januzis G Plasma rich in growth factors injection effectiveness for myofascial pain treatment in masticatory muscles. Randomised controlled trial J. Oral Rehabil. 2020 47 7 796 801 10.1111/joor.12973 32271467
Sakalys, D. et al. Plasma rich in growth factors injection effectiveness for myofascial pain treatment in masticatory muscles. Randomised controlled trial. J. Oral Rehabil. 47(7), 796–801 (2020).32271467
34. Goldberg DS McGee SJ Pain as a global public health priority BMC Public Health 2011 11 770 10.1186/1471-2458-11-770 21978149
Goldberg, D. S. & McGee, S. J. Pain as a global public health priority. BMC Public Health 11, 770 (2011).21978149
35. Goubert D De Pauw R Meeus M Lumbar muscle structure and function in chronic versus recurrent low back pain: a cross-sectional study Spine J. 2017 17 9 1285 1296 10.1016/j.spinee.2017.04.025 28456669
Goubert, D. et al. Lumbar muscle structure and function in chronic versus recurrent low back pain: a cross-sectional study. Spine J. 17(9), 1285–1296 (2017).28456669
36. Couppé C Midttun A Hilden J Spontaneous needle electromyographic activity in myofascial trigger points in the infraspinatus muscle: A blinded assessment J. Musculoskelet. Pain 2001 9 3 7 16 10.1300/J094v09n03_02
Couppé, C. et al. Spontaneous needle electromyographic activity in myofascial trigger points in the infraspinatus muscle: A blinded assessment. J. Musculoskelet. Pain 9(3), 7–16 (2001).
37. Tucker K Butler J Graven-Nielsen T Motor unit recruitment strategies are altered during deep-tissue pain J. Neurosci. 2009 29 35 10820 10826 10.1523/JNEUROSCI.5211-08.2009 19726639
Tucker, K. et al. Motor unit recruitment strategies are altered during deep-tissue pain. J. Neurosci. 29(35), 10820–10826 (2009).19726639
38. Manfredini D Cocilovo F Stellini E Surface electromyography findings in unilateral myofascial pain patients: Comparison of painful vs. non painful sides Pain Med. 2013 14 12 1848 53 10.1111/pme.12159 23746079
Manfredini, D. et al. Surface electromyography findings in unilateral myofascial pain patients: Comparison of painful vs. non painful sides. Pain Med. 14(12), 1848–53 (2013).23746079
39. Ciubotariu A Arendt-Nielsen L Graven-Nielsen T The influence of muscle pain and fatigue on the activity of synergistic muscles of the leg Eur. J. Appl. Physiol. 2004 91 5–6 604 614 10.1007/s00421-003-1026-9 14685868
Ciubotariu, A., Arendt-Nielsen, L. & Graven-Nielsen, T. The influence of muscle pain and fatigue on the activity of synergistic muscles of the leg. Eur. J. Appl. Physiol. 91(5–6), 604–614 (2004).14685868
40. Jiang, C. F., Yu, N. Y., Lin, Y. C. Exploring the differences in surface electromyographic signal between myofascial-pain and normal groups: Feature extraction through wavelet denoising and decomposition. In: Proceedings of the Int. Conf. on Signal Processing and Multimedia Applications, Seville (2011)
41. van Dieën JH Reeves NP Kawchuk G Motor control changes in low back pain: Divergence in presentations and mechanisms J. Orthop. Sports Phys. Ther. 2019 49 6 370 379 10.2519/jospt.2019.7917 29895230
van Dieën, J. H. et al. Motor control changes in low back pain: Divergence in presentations and mechanisms. J. Orthop. Sports Phys. Ther. 49(6), 370–379 (2019).29895230
42. Perry SB Stroke rehabilitation: Guidelines for exercise and training to optimize motor skill J. Neurol. Phys. Ther. 2004 28 2 101 10.1097/01.NPT.0000281192.58050.de
Perry, S. B. Stroke rehabilitation: Guidelines for exercise and training to optimize motor skill. J. Neurol. Phys. Ther. 28(2), 101 (2004).
43. Masaki M Aoyama T Murakami T Association of low back pain with muscle stiffness and muscle mass of the lumbar back muscles, and sagittal spinal alignment in young and middle-aged medical workers Clin. Biomech. (Bristol, Avon) 2017 49 128 133 10.1016/j.clinbiomech.2017.09.008 28934633
Masaki, M. et al. Association of low back pain with muscle stiffness and muscle mass of the lumbar back muscles, and sagittal spinal alignment in young and middle-aged medical workers. Clin. Biomech. (Bristol, Avon) 49, 128–133 (2017).28934633
44. Kong PW Kan TYW Bin Mohamed Jamil RAG Low back pain and biomechanical characteristics of back muscles in firefighters Ergonomics 2023 10.1080/00140139.2023.2236821 38111360
Kong, P. W. et al. Low back pain and biomechanical characteristics of back muscles in firefighters. Ergonomics10.1080/00140139.2023.2236821 (2023).38111360
45. Wu Z Ye X Ye Z Asymmetric biomechanical properties of the paravertebral muscle in elderly patients with unilateral chronic low back pain: A preliminary study Front. Bioeng. Biotechnol. 2022 10 814099 10.3389/fbioe.2022.814099 35223786
Wu, Z. et al. Asymmetric biomechanical properties of the paravertebral muscle in elderly patients with unilateral chronic low back pain: A preliminary study. Front. Bioeng. Biotechnol. 10, 814099 (2022).35223786
46. Marvulli R Ianieri G Mastromauro L Objective assessment of the rheological muscle property in the treatment of fibromyalgia Endocr. Metab. Immune Disord. Drug Targets 2015 15 3 229 233 10.2174/1871530315666150324112722 25809192
Marvulli, R. et al. Objective assessment of the rheological muscle property in the treatment of fibromyalgia. Endocr. Metab. Immune Disord. Drug Targets 15(3), 229–233 (2015).25809192
47. Kelly JP Koppenhaver SL Michener LA Immediate decrease of muscle biomechanical stiffness following dry needling in asymptomatic participants J. Bodyw. Mov. Ther. 2021 27 605 611 10.1016/j.jbmt.2021.04.014 34391295
Kelly, J. P. et al. Immediate decrease of muscle biomechanical stiffness following dry needling in asymptomatic participants. J. Bodyw. Mov. Ther. 27, 605–611 (2021).34391295
48. Ahmed S Subramaniam S Sidhu K Effect of local anesthetic versus botulinum toxin-A injections for myofascial pain disorders: A systematic review and meta-analysis Clin. J. Pain 2019 35 4 353 367 10.1097/AJP.0000000000000681 30589660
Ahmed, S. et al. Effect of local anesthetic versus botulinum toxin-A injections for myofascial pain disorders: A systematic review and meta-analysis. Clin. J. Pain 35(4), 353–367 (2019).30589660
49. Yilmaz O Sivrikaya EC Taskesen F Comparison of the efficacy of botulinum toxin, local anesthesia, and platelet-rich plasma injections in patients with myofascial trigger points in the masseter muscle J. Oral Maxillofac. Surg. 2021 79 1 881 9 10.1016/j.joms.2020.09.013
Yilmaz, O. et al. Comparison of the efficacy of botulinum toxin, local anesthesia, and platelet-rich plasma injections in patients with myofascial trigger points in the masseter muscle. J. Oral Maxillofac. Surg. 79(1), 881–9 (2021).
50. Brandl A Egner C Reer R Associations between deformation of the thoracolumbar fascia and activation of the erector spinae and multifidus muscle in patients with acute low back pain and healthy controls: A matched pair case-control study Life (Basel) 2022 12 11 1735 36362889
Brandl, A. et al. Associations between deformation of the thoracolumbar fascia and activation of the erector spinae and multifidus muscle in patients with acute low back pain and healthy controls: A matched pair case-control study. Life (Basel) 12(11), 1735 (2022).36362889
